Effort To Harmonize Cosmetics Regs Should Include Public Input – Sen. Kerry
This article was originally published in The Rose Sheet
Executive Summary
FDA should take steps to ensure that the public can participate in an initiative to bring international cosmetics regulations closer to alignment, Senator John Kerry (D-Mass.) stated in a Sept. 26 letter to FDA Commissioner Andrew von Eschenbach
You may also be interested in...
FDA preps for upcoming ICCR
Public meeting will be held June 19 in Rockville, Md. to provide information and receive comments related to International Cooperation on Cosmetics Regulations (ICCR), a voluntary effort between U.S., Japan, the EU and Canada to remove regulatory obstacles to international trade. FDA will go over topics to be discussed at second round of ICCR steering committee and expert working group meetings in Washington, D.C. the week of July 28, according to the agency's recent notice. In fall 2007, Senator John Kerry, D-Mass., lamented the public's exclusion from the first ICCR meeting in a letter to FDA Commissioner Andrew von Eschenbach (1"The Rose Sheet" Oct. 1, 2007, p. 3). An FDA document detailing the outcome of ICCR's first round of talks became available in March; FDA is accepting comments through July 2 (2"The Rose Sheet" March 10, 2008, In Brief)...
FDA preps for upcoming ICCR
Public meeting will be held June 19 in Rockville, Md. to provide information and receive comments related to International Cooperation on Cosmetics Regulations (ICCR), a voluntary effort between U.S., Japan, the EU and Canada to remove regulatory obstacles to international trade. FDA will go over topics to be discussed at second round of ICCR steering committee and expert working group meetings in Washington, D.C. the week of July 28, according to the agency's recent notice. In fall 2007, Senator John Kerry, D-Mass., lamented the public's exclusion from the first ICCR meeting in a letter to FDA Commissioner Andrew von Eschenbach (1"The Rose Sheet" Oct. 1, 2007, p. 3). An FDA document detailing the outcome of ICCR's first round of talks became available in March; FDA is accepting comments through July 2 (2"The Rose Sheet" March 10, 2008, In Brief)...
Senators Request FDA Inquiry Into Lead Discovered In Lipstick Products
FDA should "take immediate action" to reduce consumer exposure to lead in lipstick and other cosmetic products, a trio of U.S. Senators assert in a Nov. 19 letter to FDA Commissioner Andrew von Eschenbach, M.D